"We passionately believe that this partnership with The Hamner will enable companies and comprehensive cancer centers to speed development of new cancer therapies through global partnerships," said Bjarte Reve, CEO of the Oslo Cancer Cluster. "Over the last few years, we have already taken great strides in Europe to bring together such clusters, with concrete results, such as a Phase 1 network and joint EU-IMI submissions. This partnership with The Hamner is a logical next step to forge stronger links with the U.S. and also to complement our existing initiatives in China."

"The partnership with the Oslo Cancer Cluster, a world leader in cancer research and technology development, is a key link in a shared Global Biosciences Gateway and strategy to accelerate the development of new cancer therapeutics worldwide," said William Greenlee, CEO of The Hamner. "The ability we now have to identify and capture cutting-edge cancer research in Europe and China will not only benefit patients, but also will be an important driver for business and economic development in our respective countries."

SOURCE The Hamner Institutes for Health Sciences